Human Resources Contracts & Agreements in the Life Sciences Tools & Services Industry
1,436 Contracts & Agreements
- Bonus & Incentive Agreements (603 contracts from 61 companies)
- Change of Control Agreements (90 | 18)
- Compensation Agreements (112 | 31)
- Confidentiality Agreements (3 | 2)
- Consulting Agreements (45 | 23)
- Employment Agreements (433 | 51)
- Non-Competition Agreements (15 | 6)
- Retention Agreements (6 | 6)
- Retirement Agreements (12 | 7)
- Separation Agreements (71 | 26)
- Severance Agreements (39 | 14)
- Transition Agreements (7 | 7)
- 10x Genomics, Inc. (20 contracts)
- AbCellera Biologics Inc. (8)
- AbSci Corp (20)
- Adaptive Biotechnologies Corp (14)
- Agilent Technologies Inc (47)
- Akoya Biosciences, Inc. (6)
- Alpha Teknova, Inc. (9)
- ArcherDX, Inc. (3)
- ARQULE INC (29)
- ARYA Sciences Acquisition Corp III (22)
- Avantor, Inc. (16)
- Basis Global Technologies, Inc. (2)
- Berkeley Lights, Inc. (21)
- Bio-Matrix Scientific Group, Inc. (8)
- Bio-Rad Laboratories (13)
- Bio-Techne (63)
- BIOANALYTICAL SYSTEMS INC (26)
- BioNano Genomics, Inc (18)
- BRUKER CORP (21)
- Cambrex Corporation (22)
- CHAMPIONS ONCOLOGY, INC. (1)
- Charles River Laboratories (41)
- ChromaDex Corp. (29)
- CM Life Sciences II Inc. (20)
- Codex DNA, Inc. (14)
- CODEXIS INC (33)
- Cytek BioSciences, Inc. (8)
- ECO SCIENCE SOLUTIONS, INC. (30)
- EMMAUS LIFE SCIENCES, INC. (11)
- EVIO, INC. (11)
- FLUIDIGM CORP (23)
- HARVARD BIOSCIENCE INC (49)
- HighCape Capital Acquisition Corp. (25)
- Illumina Inc (28)
- IQVIA Holdings Inc. (44)
- IsoPlexis Corp (4)
- Lifesci Acquisition II Corp. (10)
- Luminex Corporation (43)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (21)
- Medpace Holdings, Inc. (16)
- Mettler Toledo (13)
- Miromatrix Medical Inc. (9)
- NanoString Technologies Inc (43)
- NEOGENOMICS INC (37)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (37)
- PerkinElmer (81)
- Personalis, Inc. (22)
- Pharma-Bio Serv, Inc. (23)
- PPD, Inc. (11)
- PRA Health Sciences (29)
- PRESSURE BIOSCIENCES INC (6)
- Quanterix Corp (24)
- RAPID MICRO BIOSYSTEMS, INC. (16)
- Repligen Corporation (21)
- Seer, Inc. (13)
- SeqLL, Inc. (8)
- Singular Genomics Systems, Inc. (4)
- Sotera Health Co (16)
- Syneos Health (45)
- Thermo Fisher Scientific (85)
- VG Acquisition Corp. (7)
- Waters Corporation (37)
- Form of Thermo Fisher Scientific Inc.s Performance Nonstatutory Stock Option Agreement between Thermo Fisher Scientific Inc. and Marc N. Casper effective as of February 21, 2024 (Thermo Fisher Scientific, Filed With SEC on May 3, 2024)
- Form of Thermo Fisher Scientific Inc.s Performance Restricted Stock Unit Agreement between Thermo Fisher Scientific Inc. and Marc N. Casper effective as of February 21, 2024 (Thermo Fisher Scientific, Filed With SEC on May 3, 2024)
- Form of Thermo Fisher Scientific Inc.s Performance Nonstatutory Stock Option Agreement effective as of February 21, 2024 (Thermo Fisher Scientific, Filed With SEC on May 3, 2024)
- Form of Thermo Fisher Scientific Inc.s Performance Restricted Stock Unit Agreement effective as of February 21, 2024 (Thermo Fisher Scientific, Filed With SEC on May 3, 2024)
- Separation Agreement and Release of All Claims by and between Illumina, Inc. and Kathryne Reeves, dates of March 19, 2024 (Illumina Inc, Filed With SEC on May 3, 2024)
- Amendment to Pharma-Bio Serv, Inc. 2014 Long-Term Incentive Plan (Pharma-Bio Serv, Inc., Filed With SEC on May 2, 2024)
- Amendment to Employment Agreement, effective April 29, 2024, by and between NeoGenomics, Inc. and Melody Harris (NEOGENOMICS INC, Filed With SEC on April 30, 2024)
- Amendment to Employment Agreement, effective April 29, 2024, by and between NeoGenomics, Inc. and Warren Stone (NEOGENOMICS INC, Filed With SEC on April 30, 2024)
- Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan, as amended (Bio-Rad Laboratories, Filed With SEC on April 26, 2024)
- Form of Medpace Holdings, Inc. 2016 Incentive Award Plan Restricted Stock Unit Award Grant Notice (Medpace Holdings, Inc., Filed With SEC on April 23, 2024)
- Form of Medpace Holdings, Inc. 2016 Incentive Award Plan Stock Option Grant Notice and Stock Option Agreement (Medpace Holdings, Inc., Filed With SEC on April 23, 2024)
- Amendment,effective as of April 11, 2024, to the Employment Agreement, dated August 3, 2023, between the Registrant and Vandana Sriram (Quanterix Corp, Filed With SEC on April 12, 2024)
- Amendment, dated April 9, 2024, to the Amended and Restated Employment Agreement, dated April 25, 2022, between the Registrant and Dr. Masoud Toloue (Quanterix Corp, Filed With SEC on April 12, 2024)
- Executive Employment Agreement between the Company and Kyle Piskel dated April 4, 2024 (Adaptive Biotechnologies Corp, Filed With SEC on April 9, 2024)
- Summary of Teknova's Non-Employee Director Compensation Policy (Alpha Teknova, Inc., Filed With SEC on March 27, 2024)
- Alpha Teknova, Inc. Annual Incentive Bonus Plan (Alpha Teknova, Inc., Filed With SEC on March 27, 2024)
- 2021 Stock Option and Incentive Plan and forms of award agreements thereunder (AbSci Corp, Filed With SEC on March 21, 2024)
- Employment Offer Letter between the Company and Roop K. Lakkaraju dated February14, 2024 (Bio-Rad Laboratories, Filed With SEC on March 20, 2024)
- Amended and Restated Incentive Compensation Recoupment Policy (ChromaDex Corp., Filed With SEC on March 6, 2024)
- Second Amended and Restated Non-Employee Director Compensation Program (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on March 1, 2024)
- Standard BioTools Inc. Amended and Restated Outside Director Equity Compensation Policy (FLUIDIGM CORP, Filed With SEC on March 1, 2024)
- Form of Performance Stock Unit Grant Notice and Performance Stock Unit Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Nonemployee Director Compensation Policy (HighCape Capital Acquisition Corp., Filed With SEC on February 29, 2024)
- Form of Restricted Stock Unit Agreement under 2021 Equity Incentive Plan (HighCape Capital Acquisition Corp., Filed With SEC on February 29, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Quanterix Corp, Filed With SEC on February 29, 2024)
- Form of Restricted Stock Unit Agreement under the 2017 Employee, Director and Consultant Equity Incentive Plan (Quanterix Corp, Filed With SEC on February 29, 2024)
- Second Amended and Restated Executive Severance Agreement, dated September 18, 2023, between the Company and Stephen Moore (Personalis, Inc., Filed With SEC on February 28, 2024)
- Third Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Richard Chen (Personalis, Inc., Filed With SEC on February 28, 2024)
- Third Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Aaron Tachibana (Personalis, Inc., Filed With SEC on February 28, 2024)
- Second Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Christopher Hall (Personalis, Inc., Filed With SEC on February 28, 2024)
- Form of Restricted Stock Unit Agreement (Time-based vesting) with single-trigger vesting acceleration upon a change of control for grants to executive officers under the 2019... (PerkinElmer, Filed With SEC on February 27, 2024)
- Form of Restricted Stock Unit Agreement (Performance-based vesting) with (PerkinElmer, Filed With SEC on February 27, 2024)
- Form of Restricted Stock Unit Agreement (Performance-based vesting) with single-trigger vesting acceleration upon a change of control for grants to executive officers under the... (PerkinElmer, Filed With SEC on February 27, 2024)
- Form of Stock Option Agreement with double-trigger vesting acceleration following a change of control for grants to executive officers under the 2019 Incentive Plan, attached... (PerkinElmer, Filed With SEC on February 27, 2024)
- Form of Stock Option Agreement with single-trigger vesting acceleration upon a change of control for grants to executive officers under the 2019 Incentive Plan, attached hereto as... (PerkinElmer, Filed With SEC on February 27, 2024)
- Revvity, Inc. Amended and Restated Global Incentive Compensation Plan (Executive Officers) effective (PerkinElmer, Filed With SEC on February 27, 2024)
- Executed Amended and Restated Employment Offer by Sotera Health Company and Jonathan M. Lyons dated as of February 26, 2024 (Sotera Health Co, Filed With SEC on February 27, 2024)
- Form of PSU Agreement under the NeoGenomics, Inc. 2023 Equity Incentive Plan (NEOGENOMICS INC, Filed With SEC on February 26, 2024)
- Form of PSU Agreement under the NeoGenomics, Inc. 2023 Equity Incentive Plan (NEOGENOMICS INC, Filed With SEC on February 23, 2024)
- Thermo Fisher Scientific Inc. Deferred Compensation Plan (Thermo Fisher Scientific, Filed With SEC on February 22, 2024)
